The evidence supporting Rose-hip for Arthritis pain relief continues to mount this past year adding to the 30 unique scientific papers published including four double-blind placebo controlled clinical trials for a patented Rose-hip Powder.
A recent review in the respected Cochrane Library, the gold standard for evidence based research, suggests there is evidence in favour of the natural anti-inflammatory Rose-hip for Osteoarthritis.
In an Australian first, July 2012 saw the highly respected Australian medical journal Australian Family Physician publish a scientific research review Rose-hip – An evidence based herbal medicine for inflammation and arthritis by the highly respected Professor Marc Cohen which suggests natural anti-inflammatory Rose-hip may offer an effective first-line therapy for Osteoarthritis.
The comprehensive review considers Rose-hip with a high safety profile and highlights a meta-analysis which concludes a patented Rose-hip powder is more efficacious than glucosamine hydrochloride in reducing osteoarthritic pain.
According to Prof Cohen in the medical journal review,the anti-inflammatory power of Rose-hip in a patented form is reported to be somewhat similar to that of a leading prescription non-steroidal anti-inflammatory drug (NSAID) although it’s mode of action is different.
“Rose-hip has been found to significantly reduce inflammation and pain for people with osteoarthritis,” Prof Cohen said.
“The anti-inflammatory properties of patented Rose-hip make it a viable replacement or supplement for conventional drug therapies in inflammatory diseases such as arthritis”, said Prof Cohen.
“More than 10 years of controlled studies of the Rose-hip powder suggest that Rose-hip may be an effective first-line therapy for osteoarthritis sufferers.”
Prof Cohen said Rose-hip’s anti-inflammatory action has been attributed to high quantities of galactolipids, a class of compounds which have shown anti-inflammatory activity in various studies.
Prof Cohen said “A particular galactolipidnamed GOPO® has been shown to be responsible for the clinically observed anti-inflammatory properties of patented Rose-hip powder.
“Research shows Rose-hip doesn’t have the potential side effects of nonsteroidal anti-inflammatory drugs and aspirin and is suitable for people at increased risk from the gastrointestinal or cardiovascular side effects of NSAID”.
The Rose-hip Studies based on the standardised Rose-hip powder – What the Research Says:
- Reduced pain scores for 287 patients in three randomized controlled trials. After three months patients who took Rose-hip were twice as likely to have reduced pain scores than people who took sugar pills.
- Rose-hip is more effective than glucosamine in reducing osteoarthritic pain. A meta-analysis of six studies, involving a total of 1222 people, compared the pain reducing effect of glucosamine and Rose-hip powder for osteoarthritis.
- Rose-hip reduced pain in 64.6% of patients in a randomised controlled trial involving 100 people with hip or knee osteoarthritis. People who took Rose-hip also experienced improve hip flexion.
- Significant reductions in pain were experience in another trial of 112 patients. In this study 66% of patients had reduced pain, reduced their consumption of pain medication and a small but significant reduction in total cholesterol.Patients in this study also experienced significant improvements in mood, wellbeing and sleep quality.
- Another placebo-controlled, double-blind crossover trial involving 94 patients with osteoarthritis of the hip or knee found treatment with Rose-hip resulted in a significant reduction in pain and use of medication’ after 3 weeks and significant reduction in disability, stiffness, and severity of the disease after 3 months of treatment.
Prof Cohen said the studies of the patented Rose-hip powder also pointed to benefits for patients with back pain and rheumatoid arthritis.